Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L G Durrant

Showing results (41-50 of 86) with videos related to

Pageof 9
Sort By:
International Journal of Cancer|April 15, 1989
The in vitro growth response of primary human colorectal and gastric cancer cells to gastrinS A Watson, L G Durrant, J D Crosbie, et al.
Gut|April 1, 1989
Hormonal control of gastric and colorectal cancer in manD L Morris, S A Watson, L G Durrant, et al.
International Journal of Cancer|April 6, 2001
Human anti-idiotypic antibodies can be good immunogens as they target FC receptors on antigen-presenting cells allowing efficient stimulation of both helper and cytotoxic T-cell responsesL G Durrant, T Parsons, R Moss, et al.
International Journal of Oncology|September 24, 1999
Separation of distinct MUC2 mucin glycoforms using two anti-peptide monoclonal antibodiesM R Price, A Ladányi, K Uray, et al.
Journal of Cell Science. Supplement|January 1, 1987
Genetic evidence for nucleotide excision repair of O6-alkylguanine in mammalian cellsJ M Boyle, L G Durrant, C P Wild, et al.
European Journal of Immunology|November 9, 2000
A therapeutic human anti-idiotypic antibody mimics CD55 in three distinct regionsL Spendlove, L Li, V Potter, et al.
British Journal of Cancer|September 17, 2009
Human leukocyte antigen class I expression is an independent prognostic factor in advanced ovarian cancer resistant to first-line platinum chemotherapyM Shehata, A Mukherjee, S Deen, et al.
Journal of the Royal College of Surgeons of Edinburgh|May 23, 2002
Current concepts in immunotherapy for the treatment of colorectal cancerA Indar, C A Maxwell-Armstrong, L G Durrant, et al.
The Journal of Pathology|August 5, 2003
Loss of CD59 expression in breast tumours correlates with poor survivalZ Madjd, S E Pinder, C Paish, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Inhibition of gastrin-stimulated growth of gastrointestinal tumour cells by octreotide and the gastrin/cholecystokinin receptor antagonists, proglumide and lorglumideS A Watson, D L Morris, L G Durrant, et al.
Pageof 9

Showing results (41-50 of 86) with videos related to

Sort By:
Pageof 9
International Journal of Cancer|April 15, 1989
The in vitro growth response of primary human colorectal and gastric cancer cells to gastrinS A Watson, L G Durrant, J D Crosbie, et al.
Gut|April 1, 1989
Hormonal control of gastric and colorectal cancer in manD L Morris, S A Watson, L G Durrant, et al.
International Journal of Cancer|April 6, 2001
Human anti-idiotypic antibodies can be good immunogens as they target FC receptors on antigen-presenting cells allowing efficient stimulation of both helper and cytotoxic T-cell responsesL G Durrant, T Parsons, R Moss, et al.
International Journal of Oncology|September 24, 1999
Separation of distinct MUC2 mucin glycoforms using two anti-peptide monoclonal antibodiesM R Price, A Ladányi, K Uray, et al.
Journal of Cell Science. Supplement|January 1, 1987
Genetic evidence for nucleotide excision repair of O6-alkylguanine in mammalian cellsJ M Boyle, L G Durrant, C P Wild, et al.
European Journal of Immunology|November 9, 2000
A therapeutic human anti-idiotypic antibody mimics CD55 in three distinct regionsL Spendlove, L Li, V Potter, et al.
British Journal of Cancer|September 17, 2009
Human leukocyte antigen class I expression is an independent prognostic factor in advanced ovarian cancer resistant to first-line platinum chemotherapyM Shehata, A Mukherjee, S Deen, et al.
Journal of the Royal College of Surgeons of Edinburgh|May 23, 2002
Current concepts in immunotherapy for the treatment of colorectal cancerA Indar, C A Maxwell-Armstrong, L G Durrant, et al.
The Journal of Pathology|August 5, 2003
Loss of CD59 expression in breast tumours correlates with poor survivalZ Madjd, S E Pinder, C Paish, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Inhibition of gastrin-stimulated growth of gastrointestinal tumour cells by octreotide and the gastrin/cholecystokinin receptor antagonists, proglumide and lorglumideS A Watson, D L Morris, L G Durrant, et al.
Pageof 9